Apoptosis in amyotrophic lateral sclerosis - What is the evidence?

Lancet Neurology

Volumn 4, Issue 8, 2005, Pages 500-509

  Sathasivam, Sivakumar ^a   Shaw, Pamela J ^b  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CREATINE; CYCLOSPORIN A; DEATH RECEPTOR; DNA FRAGMENT; FRACTIN; MINOCYCLINE; NIMODIPINE; PROSTATE APOPTOSIS RESPONSE 4 PROTEIN; PROTEIN; PROTEIN BCL 2; PROTEIN P53; RASAGILINE; RILUZOLE; UNCLASSIFIED DRUG; VERAPAMIL;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; CADAVER; CELL DEATH; CELL SURVIVAL; CLINICAL TRIAL; DISEASE COURSE; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; MORPHOLOGY; MOTONEURON; MOTOR PERFORMANCE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; APOPTOSIS; HUMANS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 22144491587     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(05)70142-3     Document Type: Review

References (98)

1. LJ Haverkamp, V Appel, SH Appel Natural history of amyotrophic lateral sclerosis in a database population: validation of a scoring system and a model for survival prediction Brain 118 1995 707 719
2. DR Rosen, T Siddique, D Patterson Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis Nature 362 1993 59 62
3. SI Liochev, I Fridovich Mutant Cu,Zn superoxide dismutases and familial amyotrophic lateral sclerosis: evaluation of oxidative hypotheses Free Radic Biol Med 34 2003 1383 1389
4. JD Wood, TP Beaujeux, PJ Shaw Protein aggregation in motor neurone disorders Neuropathol Appl Neurobiol 29 2003 529 545
5. FM Menzies, PG Ince, PJ Shaw Mitochondrial involvement in amyotrophic lateral sclerosis Neurochem Int 40 2002 543 551
6. PR Heath, PJ Shaw Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis Muscle Nerve 26 2002 438 458
7. C Raoul, AG Estévez, H Nishimune Motor neuron death triggered by a specific pathway downstream of Fas: potentiation by ALS-linked SOD1 mutations Neuron 35 2002 1067 1083
8. MV Rao, RA Nixon Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review Neurochem Res 28 2003 1041 1047
9. S Sathasivam, PG Ince, PJ Shaw Apoptosis in amyotrophic lateral sclerosis: a review of the evidence Neuropathol Appl Neurobiol 27 2001 257 274
10. C Guégan, S Przedborski Programmed cell death in amyotrophic lateral sclerosis J Clin Invest 111 2003 153 161
11. JF Kerr, AH Wyllie, AR Currie Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br J Cancer 26 1972 239 257
12. C Portera-Cailiau, D Price, LJ Martin Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum J Comp Neurol 378 1997 88 104
13. S Sperandio, I de Belle, DE Bredesen An alternative, nonapoptotic form of programmed cell death Proc Natl Acad Sci USA 97 2000 14376 14381
14. MC Dal Canto, ME Gurney Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis Am J Pathol 145 1994 1271 1279
15. JL Elliot Experimental models of amyotrophic lateral sclerosis Neurobiol Dis 6 1999 310 320
16. M Nagai, M Aoki, I Miyoshi Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease J Neurosci 21 2001 9246 9254
17. A Hirano Neuropathology of ALS: an overview Neurology 47 suppl 2 1996 S63 S66
18. MR Cookson, FM Menzies, P Manning Cu/Zn superoxide dismutase (SOD1) mutations associated with familial amyotrophic lateral sclerosis (ALS) affect cellular free radical release in the presence of oxidative stress Amyotroph Lateral Scler Other Motor Neuron Disord 3 2002 75 85
19. J Ilzecka, Z Stelmasiak Anti-annexin V antibodies in the cerebrospinal fluid and serum of patients with amyotrophic lateral sclerosis Neurol Sci 24 2003 273 274
20. N Takei, K Ohsawa, Y Imai, H Nakao, A Iwasaki, S Kohsaka Neurotrophic effects of annexin V on cultured neurons from embroyonic rat brain Neurosci Lett 171 1994 59 62
21. S Probst-Cousin, M Bergmann, C Maihofner, B Neundorfer, D Heuss Selective vulnerability in amyotrophic lateral sclerosis: no evidence for a contribution of annexins, a family of calcium binding proteins Amyotroph Lateral Scler Other Motor Neuron Disord 5 2004 180 187
22. MB Graeber, LB Moran Mechanisms of cell death in neurodegenerative diseases: fashion, fiction and facts Brain Pathol 12 2002 385 390
23. T Ekegren, E Grundström, D Lindholm, S-M Aquilonius Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons Acta Neurol Scand 100 1999 317 321
24. LJ Martin Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism J Neuropathol Exp Neurol 58 1999 459 471
25. D Troost, J Aten, F Morsink, JM de Jong Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post-central gyrus Neuropathol Appl Neurobiol 21 1995 498 504
26. Y and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis Acta Neuropathol 88 1994 207 211
27. BP He, MJ Strong Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic: a comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits Neuropathol Appl Neurobiol 26 2000 150 160
28. A Migheli, P Cavalla, S Marino, D Schiffer A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks J Neuropathol Exp Neurol 53 1994 606 616
29. A Migheli, C Atzori, R Piva Lack of apoptosis in mice with ALS Nat Med 5 1999 966 967
30. PC Ashe, MD Berry Apoptotic signaling cascades Prog Neuropsychopharmacol Biol Psychiatry 27 2003 199 214
31. D Nicholson, NA Thornberry Caspases: killer proteases Trends Biochem Sci 22 1997 299 306
32. P Pasinelli, DR Borchelt, MK Houseweart, DW Cleveland, RH Brown Jr Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase Proc Natl Acad Sci USA 95 1998 15763 15768
33. GD Ghadge, JP Lee, VP Bindokas Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection J Neurosci 17 1997 8756 8766
34. Sathasivam S, Grierson AJ, Shaw PJ, Characterization of the caspase cascade in a cell culture model of SOD1-related familial amyotrophic lateral sclerosis: expression, activation and therapeutic effects of inhibition. Neuropathol Appl Neurobiol (in press)
35. RM Friedlander, RH Brown, V Gagliardini, J Wang, J Yuan Inhibition of ICE slows ALS in mice Nature 388 1997 31
36. M Li, VO Ona, C Guégan Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model Science 288 2000 335 339
37. Y Ando, Y Liang, S Ishigaki Caspase-1 and -3 mRNAs are differentially upregulated in motor neurons and glial cells in mutant SOD1 transgenic mouse spinal cord: a study using laser microdissection and real-time RT-PCR Neurochem Res 28 2003 839 846
38. S Vukosavic, L Stefanis, V Jackson-Lewis Delaying caspase activation by Bcl-2: a clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis J Neurosci 20 2000 9119 9125
39. WPJM Spooren, B Hengerer DNA laddering and caspase 3-like activity in the spinal cord of a mouse model of familial amyotrophic lateral sclerosis Cell Mol Biol 46 2000 63 69
40. C Guégan, M Vila, P Teissman Instrumental activation of bid by caspase-1 in a transgenic mouse model of ALS Mol Cell Neurosci 20 2002 553 562
41. C Guégan, M Vila, G Rosoklija, AP Hays, S Przedborski Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis J Neurosci 21 2001 6569 6576
42. SJ Kang, I Sanchez, N Jing, J Yuan Dissociation between neurodegeneration and caspase-11-mediated activation of caspase-1 and caspase-3 in a mouse model of amyotrophic lateral sclerosis J Neurosci 23 2003 5455 5460
43. S Pampfer, I Donnay Apoptosis at the time of embryo implantation in mouse and rat Cell Death Diff 6 1999 533 545
44. H Wootz, I Hansson, L Korhonen, U Näpänkangas, D Lindholm Caspase-12 cleavage and increased oxidative stress during motoneuron degeneration in transgenic mouse model of ALS Biochem Biophys Res Commun 322 2004 281 286
45. H Fischer, U Koenig, L Eckhart, E Tschachler Human caspase 12 has acquired deleterious mutations Biochem Biophys Res Commun 293 2002 722 726
46. H Inoue, K Tsukita, T Iwasato The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model EMBO J 22 2003 6665 6674
47. N Embacher, WA Kaufman, R Beer Apoptosis signals in sporadic amyotrophic lateral sclerosis: an immunocytochemical study Acta Neuropathol 102 2001 426 434
48. T Kuwana, MR Mackey, G Perkins Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane Cell 111 2002 331 342
49. H Puthalakath, A Villunger, LA O'Reilly Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis Science 293 2001 1829 1832
50. W-X Zong, T Lindsten, AJ Ross, GR MacGregor, CB Thompson BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak Genes Dev 15 2001 1481 1486
51. T Sugiyama, S Shimizu, Y Matsuoka, Y Yoneda, Y Tsujimoto Activation of mitochondrial voltage-dependent anion channel by apro-apoptotic BH3-only protein Bim Oncogene 21 2002 4944 4956
52. N Zamzami, C El Hamel, C Maisse Bid acts on the permeability transition pore complex to induce apoptosis Oncogene 19 2000 6342 6350
53. JB Baell, DCS Huang Prospects for targeting the Bcl-2 family of proteins to develop novel cytotoxic drugs Biochem Pharmacol 64 2002 851 863
54. S Rabizadeh, EB Gralla, DR Borchelt Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an anti-apoptotic gene to a proapoptotic gene: studies in yeast and neural cells Proc Natl Acad Sci USA 92 1995 3024 3028
55. H Durham, J Roy, L Dong, DA Figlewicz Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS J Neuropathol Exp Neurol 56 1997 523 530
56. Y Patel, YC Moraes, D Latchman, R Coffin, J de Belleroche Neuroprotective effects of copper/zinc-dependent superoxide dismutase against a wide variety of death-inducing stimuli and proapoptotic effect of familial amyotrophic lateral sclerosis mutations Mol Brain Res 109 2002 189 197
57. MS Ciriolo, A De Martino, E Lafavia, L Rossi, MT Carri, G Rotilio Cu,Zn-superoxide dismutase-dependent apoptosis induced by nitric oxide in neuronal cells J Biol Chem 275 2000 5065 5072
58. V Kostic, V Jackson-Lewis, F De Bilbao, M Dubois-Dauphin, S Przedborski Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis Science 277 1997 559 562
59. S Vukosavic, M Dubois-Dauphin, N Romero, S Przedborski Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis J Neurochem 73 1999 2460 2468
60. S Vukosavic, L Stefanis, V Jackson-Lewis Delaying caspase activation by Bcl-2: a clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis J Neurosci 20 2000 9119 9125
61. JL Gonzalez de Aguilar, JW Gordon, F René Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signalling pathway Neurobiol Dis 7 2000 406 415
62. P Pasinelli, ME Belford, N Lennon Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria Neuron 43 2004 19 30
63. J Liu, C Lillo, A Jonsson Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria Neuron 43 2004 5 17
64. X Mu, J He, DW Anderson, JQ Trojanowski, JE Springer Altered expression of bcl-2 andbax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons Ann Neurol 40 1996 379 386
65. T Shinoe, A Wanaka, T Nikaido Upregulation of the proapoptotic BH3-only peptide hara-kiri in spinal neurones of amyotrophic lateral sclerosis patients Neurosci Lett 313 2001 153 157
66. N Embacher, WA Kaufman, R Beer Apoptosis signals in sporadic amyotrophic lateral sclerosis: an immunocytochemical study Acta Neuropathol 102 2001 426 434
67. Y antigen expression is correlated with apoptosis (programmed cell death) Glycobiology 3 1993 381 390
68. F Yang, X Sun, W Beech Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease Am J Pathol 152 1998 379 389
69. SF Sells, SS Han, S Muthukkumar Expression and function of the leucine zipper protein Par-4 in apoptosis Mol Cell Biol 17 1997 3823 3832
70. N El-Guendy, VM Rangnekar Apoptosis by Par-4 in cancer and neurodegenerative diseases Exp Cell Res 283 2003 51 66
71. WA Pedersen, H Luo, I Kruman, E Kasarskis, MP Mattson The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis FASEB J 14 2000 913 924
72. J Xie, KS Awad, Q Guo RNAi knockdown of Par-4 inhibits neurosynaptic degeneration in ALS-linked mice J Neurochem 92 2005 59 71
73. C Raoul, CE Henderson, B Pettmann Programmed cell death of embryonic motoneurons triggered through the Fas death receptor J Cell Biol 147 1999 1049 1062
74. FH Yi, C Lautrette, C Vermot-Desroches In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients J Neuroimmunol 109 2000 211 220
75. IS Sengun, SH Appel Serum anti-Fas antibody levels in amyotrophic lateral sclerosis J Neuroimmunol 142 2003 137 140
76. K Hensley, RA Floyd, B Gordon Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis J Neurochem 82 2002 365 374
77. RS Morisson, Y Kinoshita, MD Johnson, W Guo, GA Garden p53-dependent cell death signaling in neurons Neurochem Res 28 2003 15 27
78. MD Shahbazian, HT Orr, HY Zoghbi Reduction of purkinje cell pathology in SCA1 transgenic mice by p53 deletion Neurobiol Dis 8 2001 974 981
79. SM De la Monte, YK Sohn, N Ganju, JR Wands p53- and CD95-associated apoptosis in neurodegenerative disease Lab Invest 78 1998 401 411
80. C Kuntz, Y Kinoshita, MF Beal, LA Donehower, RS Morrison Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis Exp Neurol 165 2000 184 190
81. J Prudlo, J Koenig, J Graser Motor neuron cell death in a mouse model of FALS is not mediated by the p53 cell survival regulator Brain Res 879 2000 183 187
82. TM Tikka, NE Vartiainen, G Goldsteins Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease Brain 125 2002 722 731
83. J Kriz, MD Nguyen, J-P Julien Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis Neurobiol Dis 10 2002 268 278
84. L Van Den Bosch, P Tilkin, G Lemmens, W Robberecht Minocycline delays disease onset and mortality in a transgenic model of ALS Neuroreport 13 2002 1067 1070
85. S Zhu, IG Stavrovskaya, M Drozda Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice Nature 417 2002 74 78
86. W Zhang, M Narayanan, RM Friedlander Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS Ann Neurol 53 2003 267 270
87. J Kriz, G Gowing, J-P Julien Efficient three-drug cocktail for disease induced by mutant superoxide dismutase Ann Neurol 53 2003 429 436
88. PH Gordon, DH Moore, DF Gelinas Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis Neurology 62 2004 1845 1847
89. RG Miller, R Shepherd, H Dao Controlled trial of nimodipine in amyotrophic lateral sclerosis Neuromuscul Disord 6 1996 101 104
90. RG Miller, SA Smith, JR Murphy Clinical trial of verapamil in amyotrophic lateral sclerosis Muscle Nerve 19 1996 511 515
91. 2+ channel antagonists suppress the release of cytochrome c and the expression of procaspase-3 in rat hippocampus after global brain ischaemia Neurosci Lett 328 2002 265 268
92. S Yamanaka, T Tatsumi, J Shiraishi Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes J Am Coll Cardiol 41 2003 870 878
93. IG Kirkinezos, D Hernandez, WG Bradley, CT Moraes An ALS mouse model with a permeable blood-brain barrier benefits from systemic cyclosporine A treatment J Neurochem 88 2004 821 826
94. I Szabo, M Zoratti The giant channel of the inner mitochondrial membrane is inhibited by cyclosporin A J Biol Chem 266 1991 3376 3379
95. PC Harrison, JB Madwed Anti-LFA-1α reduces the dose of cyclosporin A needed to produce immunosuppression in heterotopic cardiac transplanted rats J Heart Lung Transplant 18 1999 279 284
96. S Waibel, A Reuter, S Malessa, E Blaugrund, AC Ludolph Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model J Neurol 251 2004 1080 1084
97. MB Youdim, M Fridkin, H Zheng Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases Mech Ageing Dev 126 2005 317 326
98. PC Waldmeier Prospects for antiapoptotic drug therapy of neurodegenerative diseases Prog Neuropsychopharmacol Biol Psychiatry 27 2003 303 321